Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

140 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Non-alcoholic steatohepatitis: pathogenesis and novel therapeutic approaches.
Schuppan D, Schattenberg JM. Schuppan D, et al. Among authors: schattenberg jm. J Gastroenterol Hepatol. 2013 Aug;28 Suppl 1:68-76. doi: 10.1111/jgh.12212. J Gastroenterol Hepatol. 2013. PMID: 23855299 Review.
Prevention of endpoints in primary biliary cholangitis with ursodeoxycholic acid: quantifying the benefit.
Schattenberg JM. Schattenberg JM. Gut. 2020 Aug;69(8):1377-1378. doi: 10.1136/gutjnl-2019-320355. Epub 2020 Mar 23. Gut. 2020. PMID: 32205421 No abstract available.
JNK1 but not JNK2 promotes the development of steatohepatitis in mice.
Schattenberg JM, Singh R, Wang Y, Lefkowitch JH, Rigoli RM, Scherer PE, Czaja MJ. Schattenberg JM, et al. Hepatology. 2006 Jan;43(1):163-72. doi: 10.1002/hep.20999. Hepatology. 2006. PMID: 16374858
Apoptosis in liver disease.
Schattenberg JM, Galle PR, Schuchmann M. Schattenberg JM, et al. Liver Int. 2006 Oct;26(8):904-11. doi: 10.1111/j.1478-3231.2006.01324.x. Liver Int. 2006. PMID: 16953829 Review.
Diabetes and apoptosis: liver.
Schattenberg JM, Schuchmann M. Schattenberg JM, et al. Apoptosis. 2009 Dec;14(12):1459-71. doi: 10.1007/s10495-009-0366-2. Apoptosis. 2009. PMID: 19544096 Review.
Shortcut to death.
Schattenberg JM, Schuchmann M. Schattenberg JM, et al. Hepatology. 2009 Dec;50(6):2040-3. doi: 10.1002/hep.23400. Hepatology. 2009. PMID: 19937700 No abstract available.
Cell death and hepatocarcinogenesis: Dysregulation of apoptosis signaling pathways.
Schattenberg JM, Schuchmann M, Galle PR. Schattenberg JM, et al. J Gastroenterol Hepatol. 2011 Jan;26 Suppl 1:213-9. doi: 10.1111/j.1440-1746.2010.06582.x. J Gastroenterol Hepatol. 2011. PMID: 21199533 Review.
Alterations in lipid, carbohydrate and iron metabolism in patients with non-alcoholic steatohepatitis (NASH) and metabolic syndrome.
Zimmermann A, Zimmermann T, Schattenberg J, Pöttgen S, Lotz J, Rossmann H, Roeddiger R, Biesterfeld S, Geiss HC, Schuchmann M, Galle PR, Weber MM. Zimmermann A, et al. Among authors: schattenberg j. Eur J Intern Med. 2011 Jun;22(3):305-10. doi: 10.1016/j.ejim.2011.01.011. Epub 2011 Feb 12. Eur J Intern Med. 2011. PMID: 21570653
Ablation of c-FLIP in hepatocytes enhances death-receptor mediated apoptosis and toxic liver injury in vivo.
Schattenberg JM, Zimmermann T, Wörns M, Sprinzl MF, Kreft A, Kohl T, Nagel M, Siebler J, Schulze Bergkamen H, He YW, Galle PR, Schuchmann M. Schattenberg JM, et al. J Hepatol. 2011 Dec;55(6):1272-80. doi: 10.1016/j.jhep.2011.03.008. Epub 2011 Apr 15. J Hepatol. 2011. PMID: 21703207
Nonalcoholic steatohepatitis: the therapeutic challenge of a global epidemic.
Schattenberg JM, Schuppan D. Schattenberg JM, et al. Curr Opin Lipidol. 2011 Dec;22(6):479-88. doi: 10.1097/MOL.0b013e32834c7cfc. Curr Opin Lipidol. 2011. PMID: 22002020 Review.
140 results
Jump to page
Feedback